Investor Relations

Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Evolent Health, Inc. (Arlington, VA)
Event Date 12/5/2016
Filing Date 12/5/2016

Abstract: Registrant reported that on Nov. 29, it and Evolent Health LLC entered into a purchase agreement JP Morgan Securities LLC and Goldman Sachs & Co. issue and sell $110.0 million aggregate principal amount of its 2.00% convertible senior notes due 2021. The indenture, among other things, was included by exhibit.

File Section(s)

  1. 8-K
  2. EXHIBIT 4.1
  3. EXHIBIT 10.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.